Zhejiang CONBA Pharmaceutical Co Ltd
SSE:600572
Wall Street
Price Targets
Price Targets Summary
Zhejiang CONBA Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 5.4 CNY .
Revenue
Forecast
Revenue Estimate
Zhejiang CONBA Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 16%.
Operating Income
Forecast
Operating Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 12%.
Net Income
Forecast
Net Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is -5%. The projected CAGR for the next 3 years is 40%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang CONBA Pharmaceutical Co Ltd's stock price target?
Price Target
5.4
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 5.4 CNY .
What is Zhejiang CONBA Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 16%.
What is Zhejiang CONBA Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 12%.
What is Zhejiang CONBA Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
40%
For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is -5%. The projected CAGR for the next 3 years is 40%.